|
US6673779B2
(en)
|
1996-03-27 |
2004-01-06 |
Inspire Pharmaceuticals, Inc. |
Method of treating ciliary dyskinesia with dinucleoside polyphosphate compounds or UTP analogues
|
|
US6319908B1
(en)
|
1996-07-03 |
2001-11-20 |
Inspire Pharmaceuticals, Inc. |
Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof
|
|
US5763447C1
(en)
|
1996-07-23 |
2002-05-07 |
Inspire Pharmaceuticals |
Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds
|
|
DK0981534T3
(da)
|
1997-02-06 |
2006-09-04 |
Inspire Pharmaceuticals Inc |
Dinukleotider og deres anvendelser
|
|
US7078391B2
(en)
*
|
1997-02-10 |
2006-07-18 |
Inspire Pharmaceuticals, Inc. |
Method of treating edematous retinal disorders
|
|
US6596725B2
(en)
*
|
1997-02-10 |
2003-07-22 |
Inspire Pharmaceuticals, Inc. |
Use of certain dinucleotides to stimulate removal of fluid in retinal detachment and retinal edema
|
|
US7223744B2
(en)
|
1997-02-10 |
2007-05-29 |
Inspire Pharmaceuticals, Inc. |
Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof
|
|
US6818629B2
(en)
*
|
1997-02-10 |
2004-11-16 |
Inspire Pharmaceuticals, Inc. |
Pharmaceutical formulation comprising P1-(2'-deoxycytidine 5'-)P4-(uridine 5'-) tetraphosphate
|
|
US6462028B2
(en)
|
1997-07-25 |
2002-10-08 |
Inspire Pharmaceuticals, Inc. |
Method of promoting cervical and vaginal secretions
|
|
TW593331B
(en)
|
1997-07-25 |
2004-06-21 |
Inspire Pharmaceuticals Inc |
Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof
|
|
US6548658B2
(en)
*
|
1997-07-25 |
2003-04-15 |
Inspire Pharmaceuticals, Inc. |
Di-(uridine 5′)-tetraphosphate and salts thereof
|
|
KR20010013797A
(ko)
|
1997-07-25 |
2001-02-26 |
인스파이어 파마슈티컬스 인코퍼레이티드 |
디(우리딘 5'-테트라포스페이트) 염 및 그의 제조방법과용도
|
|
US6872710B2
(en)
|
1997-07-25 |
2005-03-29 |
Inspire Pharmaceuticals, Inc. |
Di(uridine 5′)-tetraphosphate and salts thereof
|
|
ID29198A
(id)
*
|
1997-08-29 |
2001-08-09 |
Univ North Carolina |
Pemakaian uridin 5'-difosfat dan persamaannya untuk mengobati penyakit paru-paru
|
|
CA2332540A1
(en)
*
|
1998-05-22 |
1999-12-02 |
Benjamin R. Yerxa |
Therapeutic dinucleotide and derivatives
|
|
WO2000039145A1
(en)
*
|
1998-12-23 |
2000-07-06 |
The University Of North Carolina At Chapel Hill |
Targeted gene transfer using g protein coupled receptors
|
|
WO2000050024A2
(en)
|
1999-02-26 |
2000-08-31 |
Inspire Pharmaceuticals, Inc. |
Method of promoting mucosal hydration with certain uridine, adenine and cytidine diphosphates and analogs thereof
|
|
WO2001002416A1
(en)
*
|
1999-06-30 |
2001-01-11 |
Yamasa Corporation |
Dinucleotide crystals
|
|
WO2001012644A1
(en)
*
|
1999-08-17 |
2001-02-22 |
Adani, Alexander |
Dinucleoside 5',5'-tetraphosphates as inhibitors of viral reverse transcriptases and viruses
|
|
AU2603101A
(en)
*
|
1999-12-22 |
2001-07-03 |
Inspire Pharmaceuticals, Inc. |
Method of treating gastrointestinal tract disease with purinergic receptor agonists
|
|
RU2161982C1
(ru)
*
|
2000-01-20 |
2001-01-20 |
Общество с ограниченной ответственностью "Клиника Института биорегуляции и геронтологии" |
Тетрапептид, стимулирующий функцию сетчатой оболочки глаза, фармакологическое средство на его основе и способ его применения
|
|
US6864243B1
(en)
*
|
2000-05-12 |
2005-03-08 |
Inspire Pharmaceuticals, Inc. |
Method for treating retinal degeneration with purinergic receptor agonists
|
|
BR0111297A
(pt)
*
|
2000-05-30 |
2004-01-06 |
Santen Pharmaceutical Co Ltd |
Promotor de migração epitelial corneana
|
|
US6867199B2
(en)
|
2000-08-21 |
2005-03-15 |
Inspire Pharmaceuticals, Inc. |
Dinucleoside polyphosphate compositions and their therapeutic use
|
|
US7132408B2
(en)
*
|
2000-08-21 |
2006-11-07 |
Inspire Pharmaceuticals, Inc. |
Composition and method for inhibiting platelet aggregation
|
|
US7115585B2
(en)
*
|
2000-08-21 |
2006-10-03 |
Inspire Pharmaceuticals, Inc. |
Compositions for treating epithelial and retinal tissue diseases
|
|
US6555675B2
(en)
*
|
2000-08-21 |
2003-04-29 |
Inspire Pharmaceuticals, Inc. |
Dinucleoside polyphosphate compositions and their therapuetic use as purinergic receptor agonists
|
|
US7018985B1
(en)
|
2000-08-21 |
2006-03-28 |
Inspire Pharmaceuticals, Inc. |
Composition and method for inhibiting platelet aggregation
|
|
US7452870B2
(en)
*
|
2000-08-21 |
2008-11-18 |
Inspire Pharmaceuticals, Inc. |
Drug-eluting stents coated with P2Y12 receptor antagonist compound
|
|
WO2002048165A2
(en)
*
|
2000-12-15 |
2002-06-20 |
Pharmasset Ltd. |
Antiviral agents for treatment of flaviviridae infections
|
|
US20040122223A1
(en)
*
|
2001-02-07 |
2004-06-24 |
Davis Jeremy Martin |
Non-natural nucleotides and dinucleotides
|
|
WO2003000056A1
(en)
|
2001-06-25 |
2003-01-03 |
Inspire Pharmaceuticals, Inc. |
Joint lubrication with p2y purinergic receptor agonists
|
|
EP1409503A1
(en)
*
|
2001-07-25 |
2004-04-21 |
Celltech R & D Limited |
Non-natural carbon-linked nucleotides and dinucleotides
|
|
WO2003030892A1
(en)
*
|
2001-10-11 |
2003-04-17 |
Alcon, Inc. |
Methods for treating dry eye
|
|
KR20050043761A
(ko)
|
2001-11-06 |
2005-05-11 |
인스파이어 파마슈티컬스 인코퍼레이티드 |
염증성 질환의 치료 또는 예방 방법
|
|
US7084128B2
(en)
|
2002-01-18 |
2006-08-01 |
Inspire Pharmaceuticals, Inc. |
Method for reducing intraocular pressure
|
|
MXPA05004121A
(es)
*
|
2002-10-18 |
2006-02-17 |
Molichem Medicines Inc |
Metodos para tratar la enfermedad de ojo reseco con lantibioticos.
|
|
US6984628B2
(en)
*
|
2003-07-15 |
2006-01-10 |
Allergan, Inc. |
Ophthalmic compositions comprising trefoil factor family peptides
|
|
US7326683B2
(en)
*
|
2004-05-06 |
2008-02-05 |
Molichem Medicines, Inc. |
Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions
|
|
CA2565545A1
(en)
*
|
2004-05-06 |
2005-12-08 |
Molichem Medicines, Inc. |
Treatment of ocular diseases and disorders using lantibiotic compositions
|
|
GB0417886D0
(en)
*
|
2004-08-11 |
2004-09-15 |
Univ Cardiff |
Method and means for enhanced pulmonary delivery
|
|
GB0502250D0
(en)
*
|
2005-02-03 |
2005-03-09 |
Ic Vec Ltd |
Use
|
|
US7368439B2
(en)
*
|
2005-06-15 |
2008-05-06 |
Bar - Ilan University |
Dinucleoside poly(borano)phosphate derivatives and uses thereof
|
|
US7851456B2
(en)
*
|
2005-06-29 |
2010-12-14 |
Inspire Pharmaceuticals, Inc. |
P2Y6 receptor agonists for treating lung diseases
|
|
EP2036567A3
(en)
|
2005-12-06 |
2009-12-09 |
P2-Science APS |
Modulation of the P2Y2 receptor pathway
|
|
US20070249556A1
(en)
*
|
2006-04-21 |
2007-10-25 |
Brubaker Kurt E |
Method of treating inflammation
|
|
CN101495497B
(zh)
*
|
2006-07-26 |
2012-03-14 |
Yamasa酱油株式会社 |
二(嘧啶核苷5’-)多磷酸的制备方法
|
|
EP2049665A2
(en)
*
|
2006-07-28 |
2009-04-22 |
Applera Corporation |
Dinucleotide mrna cap analogs
|
|
CA2702094C
(en)
|
2007-10-10 |
2018-05-01 |
Parion Sciences, Inc. |
Delivering osmolytes by nasal cannula
|
|
US8168597B2
(en)
*
|
2008-10-22 |
2012-05-01 |
Inspire Pharmaceuticals, Inc. |
Method for treating cystic fibrosis
|
|
US9067964B2
(en)
|
2008-12-18 |
2015-06-30 |
Oligomer Sciences Ab |
Complex and method for enhancing nuclear delivery
|
|
WO2012031186A1
(en)
|
2010-09-03 |
2012-03-08 |
Wisconsin Pharmacal Company, Llc. |
Prebiotic suppositories
|
|
PL2614838T3
(pl)
*
|
2010-09-10 |
2016-10-31 |
|
Dikwafozol i kwas hialuronowy lub ich sole do zastosowania w leczeniu zespołu suchego oka
|
|
EP2717855A4
(en)
|
2011-06-07 |
2014-11-12 |
Parion Sciences Inc |
Methods of Treatment
|
|
US8945605B2
(en)
|
2011-06-07 |
2015-02-03 |
Parion Sciences, Inc. |
Aerosol delivery systems, compositions and methods
|
|
AR086745A1
(es)
|
2011-06-27 |
2014-01-22 |
Parion Sciences Inc |
3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
|
|
EP3431092A1
(en)
|
2012-03-26 |
2019-01-23 |
Santen Pharmaceutical Co., Ltd. |
Ophthalmic solution comprising diquafosol
|
|
HUE039734T2
(hu)
|
2012-05-29 |
2019-01-28 |
Parion Sciences Inc |
Nátriumcsatorna-blokkoló aktivitású, dendrimerszerû amino-amid-származékok száraz szem és más nyálkahártya-megbetegedések kezelésére
|
|
CN108658876A
(zh)
|
2012-12-17 |
2018-10-16 |
帕里昂科学公司 |
3,5-二氨基-6-氯-n-(n-(4-苯基丁基)甲脒基)吡嗪-2-甲酰胺化合物
|
|
ES2674665T3
(es)
|
2012-12-17 |
2018-07-03 |
Parion Sciences, Inc. |
Compuestos de 3,5-diamino-6-cloro-N-(N-(4-fenilbutilo)carbamimidoilo)-pirazina-2-carboxamida
|
|
CA2895512C
(en)
|
2012-12-17 |
2021-10-19 |
Parion Sciences, Inc. |
Chloro-pyrazine carboxamide derivatives useful for the treatment of diseases favoured by insufficient mucosal hydration
|
|
US10323058B2
(en)
|
2014-07-24 |
2019-06-18 |
W. R. Grace & Co.-Conn. |
Crystalline form of nicotinamide riboside
|
|
EP3268379B1
(en)
|
2015-03-09 |
2023-11-01 |
W.R. Grace & CO. - CONN. |
Crystalline form of nicotinamide riboside
|
|
US20180125876A1
(en)
|
2015-05-20 |
2018-05-10 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Methods and Pharmaceutical Composition for Modulation Polarization and Activation of Macrophages
|
|
CN112020363A
(zh)
|
2017-12-22 |
2020-12-01 |
益力舒健康公司 |
烟酰胺核苷氯化物的结晶形式
|
|
EP4157288A2
(en)
|
2020-06-02 |
2023-04-05 |
Institut Gustave-Roussy |
Modulators of purinergic receptors and related immune checkpoint for treating acute respiratory distress syndrom
|
|
EP3919062A1
(en)
|
2020-06-02 |
2021-12-08 |
Institut Gustave-Roussy |
Modulators of purinergic receptors and related immune checkpoint for treating acute respiratory distress syndrom
|